Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Metformin prevents metabolic side effects during systemic glucocorticoid treatment.

Seelig E, Meyer S, Timper K, Nigro N, Bally M, Pernicova I, Schuetz P, Müller B, Korbonits M, Christ-Crain M.

Eur J Endocrinol. 2017 Mar;176(3):349-358. doi: 10.1530/EJE-16-0653. Epub 2017 Jan 10.

PMID:
28073907
2.

Interleukin-1 antagonism in type 1 diabetes of long duration.

Seelig E, Timper K, Falconnier C, Stoeckli R, Bilz S, Oram R, McDonald TJ, Donath MY.

Diabetes Metab. 2016 Dec;42(6):453-456. doi: 10.1016/j.diabet.2016.08.005. Epub 2016 Oct 5. No abstract available.

PMID:
27720360
3.

Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.

Cabrera SM, Wang X, Chen YG, Jia S, Kaldunski ML, Greenbaum CJ; Type 1 Diabetes TrialNet Canakinumab Study Group, Mandrup-Poulsen T; AIDA Study Group, Hessner MJ.

Eur J Immunol. 2016 Apr;46(4):1030-46. doi: 10.1002/eji.201546005. Epub 2016 Jan 21.

4.

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.

Cavelti-Weder C, Timper K, Seelig E, Keller C, Osranek M, Lässing U, Spohn G, Maurer P, Müller P, Jennings GT, Willers J, Saudan P, Donath MY, Bachmann MF.

Mol Ther. 2016 May;24(5):1003-12. doi: 10.1038/mt.2015.227. Epub 2015 Dec 21.

5.

Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.

Nordmann TM, Seelig E, Timper K, Cordes M, Coslovsky M, Hanssen H, Schmidt-Trucksäss A, Donath MY.

PLoS One. 2015 Oct 8;10(10):e0139662. doi: 10.1371/journal.pone.0139662. eCollection 2015.

6.

Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus.

Timper K, Seelig E, Tsakiris DA, Donath MY.

J Diabetes Complications. 2015 Sep-Oct;29(7):955-60. doi: 10.1016/j.jdiacomp.2015.05.019. Epub 2015 Jun 3.

PMID:
26139558
7.

Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.

Seelig E, Bilz S, Keller U, Meienberg F, Christ-Crain M.

PLoS One. 2013 Aug 30;8(8):e72876. doi: 10.1371/journal.pone.0072876. eCollection 2013.

8.

Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study.

Seelig E, Keller U, Klarhöfer M, Scheffler K, Brand S, Holsboer-Trachsler E, Hatzinger M, Bilz S.

PLoS One. 2013 Apr 12;8(4):e61780. doi: 10.1371/journal.pone.0061780. Print 2013.

9.

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet Canakinumab Study Group, Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T; AIDA Study Group.

Lancet. 2013 Jun 1;381(9881):1905-15. doi: 10.1016/S0140-6736(13)60023-9. Epub 2013 Apr 5.

10.

Spatial confinement of laser light in active random media

Cao H, Xu JY, Zhang DZ, Chang S, Ho ST, Seelig EW, Liu X, Chang RP.

Phys Rev Lett. 2000 Jun 12;84(24):5584-7.

PMID:
10991000
11.

[Life time of linoleic acid in the organism of rats].

WAGNER H, SEELIG E, BERNHARD K.

Hoppe Seylers Z Physiol Chem. 1958;313:235-43. German. No abstract available.

PMID:
13620240
12.

[Distribution and half life of erucic acid after rape seed oil administration in rats].

WAGNER H, SEELIG E, BERNHARD K.

Hoppe Seylers Z Physiol Chem. 1958;312(1-3):104-10. German. No abstract available.

PMID:
13598407
13.

[Biochemistry of essential fatty acids. I. Alleged effect of the nutritional fats on the fatty acid composition of body lipids].

WAGNER H, SEELIG E, BERNHARD K.

Schweiz Med Wochenschr. 1957 Nov 23;87(47):1423-7. German. No abstract available.

PMID:
13519078
14.

[Determination of the participation of fatty acids in dietary and depot fats in building-up of liver fats, and in fatty degeneration of liver induced by choline deficiency].

WAGNER H, SEELIG E, BERNHARD K.

Hoppe Seylers Z Physiol Chem. 1956 Dec 10;306(2-3):96-103. German. No abstract available.

PMID:
13405482
15.

[Secretion of body fat in the intestinal lumen].

BERNHARD K, SEELIG E, WAGNER H.

Hoppe Seylers Z Physiol Chem. 1956 May 28;304(2-4):138-47. German. No abstract available.

PMID:
13331499

Supplemental Content

Loading ...
Support Center